Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Jonathan Chou, M.D., Ph.D.
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Jonathan Chou, M.D., Ph.D.
I am a physician-scientist broadly interested in translational oncology and am currently an Instructor in the Division of Hematology/Oncology and postdoctoral research fellow in the Feng Lab (http://fenglaboratory.com/) and Ashworth Lab.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of Michigan Rogel Cancer Center
- ID
- NCT03570619
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated